MeiraGTx Holdings plc Finance Lease, Interest Payment on Liability
MeiraGTx Holdings plc (MGTX) reported Finance Lease, Interest Payment on Liability of $52.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-15.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FinanceLeaseInterestPaymentOnLiability · last filed 2024-03-15
- MeiraGTx Holdings plc finance lease, interest payment on liability for the quarter ending 2022-12-31 was $41.00K, a 925.00% increase year-over-year.
- MeiraGTx Holdings plc finance lease, interest payment on liability for the quarter ending 2022-09-30 was $4.00K, a 0.00% change year-over-year.
- MeiraGTx Holdings plc finance lease, interest payment on liability for the quarter ending 2022-06-30 was $4.00K, a 0.00% change year-over-year.
- MeiraGTx Holdings plc finance lease, interest payment on liability for the quarter ending 2022-03-31 was $4.00K, a 0.00% change year-over-year.
- MeiraGTx Holdings plc finance lease, interest payment on liability for fiscal 2022 was $52.00K, a 225.00% increase from fiscal 2021.
- MeiraGTx Holdings plc finance lease, interest payment on liability for fiscal 2021 was $16.00K, a 27.27% decline from fiscal 2020.
- MeiraGTx Holdings plc finance lease, interest payment on liability for fiscal 2020 was $22.00K, a 21.95% decline from fiscal 2019.
- MeiraGTx Holdings plc finance lease, interest payment on liability for fiscal 2019 was $28.19K.
| Period end | Finance Lease, Interest Payment on Liability 3 month | Finance Lease, Interest Payment on Liability 3 month as first filed | Finance Lease, Interest Payment on Liability 6 month | Finance Lease, Interest Payment on Liability 6 month as first filed | Finance Lease, Interest Payment on Liability 9 month | Finance Lease, Interest Payment on Liability 9 month as first filed | Finance Lease, Interest Payment on Liability 12 month | Finance Lease, Interest Payment on Liability 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2022-12-31 | $41.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $45.00K derived: sum of 2 quarters · filed 2024-03-15 | $49.00K derived: sum of 3 quarters · filed 2024-03-15 | $52.00K 10-K · filed 2024-03-15 | ||||
| 2022-09-30 | $4.00K 10-Q · filed 2023-11-14 | $8.00K derived: sum of 2 quarters · filed 2023-11-14 | $11.00K 10-Q · filed 2023-11-14 | $16.00K derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $4.00K 10-Q · filed 2023-08-10 | $8.00K 10-Q · filed 2023-08-10 | $12.00K derived: sum of 3 quarters · filed 2023-08-10 | $16.00K derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | $4.00K 10-Q · filed 2023-05-11 | $8.00K derived: sum of 2 quarters · filed 2023-05-11 | $12.00K derived: sum of 3 quarters · filed 2023-05-11 | $16.00K derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $8.00K derived: sum of 2 quarters · filed 2023-03-14 | $12.00K derived: sum of 3 quarters · filed 2023-03-14 | $16.00K 10-K · filed 2023-03-14 | ||||
| 2021-09-30 | $4.00K 10-Q · filed 2022-11-10 | $8.00K derived: sum of 2 quarters · filed 2022-11-10 | $12.00K 10-Q · filed 2022-11-10 | $17.00K derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $4.00K 10-Q · filed 2022-08-11 | $8.00K 10-Q · filed 2022-08-11 | $13.00K derived: sum of 3 quarters · filed 2022-08-11 | $17.00K derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | $4.00K 10-Q · filed 2022-05-12 | $9.00K derived: sum of 2 quarters · filed 2022-05-12 | $13.00K derived: sum of 3 quarters · filed 2022-05-12 | $19.00K derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $9.00K derived: sum of 2 quarters · filed 2022-03-10 | $15.00K derived: sum of 3 quarters · filed 2022-03-10 | $22.00K 10-K · filed 2022-03-10 | $21.60K 10-K · filed 2021-03-11 | |||
| 2020-09-30 | $4.00K 10-Q · filed 2021-11-10 | $3.73K 10-Q · filed 2020-11-05 | $10.00K derived: sum of 2 quarters · filed 2021-11-10 | $17.00K 10-Q · filed 2021-11-10 | $17.21K 10-Q · filed 2020-11-05 | $25.96K derived: sum of 4 quarters · filed 2021-11-10 | ||
| 2020-06-30 | $6.00K 10-Q · filed 2021-08-11 | $5.58K 10-Q · filed 2020-08-06 | $13.00K 10-Q · filed 2021-08-11 | $13.48K 10-Q · filed 2020-08-06 | $21.96K derived: sum of 3 quarters · filed 2021-08-11 | $28.82K derived: sum of 4 quarters · filed 2021-08-11 | ||
| 2020-03-31 | $8.00K 10-Q · filed 2021-05-11 | $7.90K 10-Q · filed 2020-05-07 | $15.96K derived: sum of 2 quarters · filed 2021-05-11 | $22.82K derived: sum of 3 quarters · filed 2021-05-11 | $29.56K derived: sum of 4 quarters · filed 2021-05-11 | |||
| 2019-12-31 | $7.96K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $14.82K derived: sum of 2 quarters · filed 2021-03-11 | $21.56K derived: sum of 3 quarters · filed 2021-03-11 | $28.19K 10-K · filed 2021-03-11 | ||||
| 2019-09-30 | $6.86K 10-Q · filed 2020-11-05 | $13.60K derived: sum of 2 quarters · filed 2020-11-05 | $20.22K 10-Q · filed 2020-11-05 | $28.19K 10-K · filed 2020-03-11 | ||||
| 2019-06-30 | $6.74K 10-Q · filed 2020-08-06 | $13.37K 10-Q · filed 2020-08-06 | ||||||
| 2019-03-31 | $6.63K 10-Q · filed 2020-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |